Clinical Experience and Perspectives of Bosutinib Use in Patients with Chronic Myeloid Leukemia

Aim. To evaluate the clinical experience of bosutinib use for treatment of chronic myeloid leukemia (CML) patients with intolerance and resistance to other tyrosine kinase inhibitors (TKI), as well as to compare the obtained results with the data of clinical trials. Materials & Methods. The analy...

Descrizione completa

Dettagli Bibliografici

Autori principali:	V. A. Shuvaev, Ol’ga Yur’evna Vinogradova, I. S. Martynkevich, N. V. Novitskaya, M. S. Fominykh, S. N. Tsareva, D. I. Shikhbabaeva, M. M. Pankrashkina, M. V. Chernikov, N. N. Sharkunov, I. I. Zotova, V. Yu. Udal’eva, E. V. Motyko, S. V. Voloshin
Natura:	Artigo
Lingua:	Russo
Pubblicazione:	Practical Medicine Publishing House 2018-10-01
Serie:	Клиническая онкогематология
Soggetti:	chronic myeloid leukemia bosutinib target therapy tyrosine kinase inhibitors clinical practice
Accesso online:	https://bloodjournal.ru/index.php/coh/article/view/377
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!